YOUR BEAUTIQUE LIMITED

1. Financial Health Score: D+

Explanation: While the business has a pulse and maintains a seemingly healthy cash balance, it is suffering from acute equity depletion and negative working capital. The "healthy" cash reserves are largely an illusion, funded by a massive surge in short-term creditors rather than trading profits. The business is currently surviving on financial life support.

2. Key Vital Signs

• Equity Erosion (Financial Blood Pressure): Net assets have plummeted from £10,123 in 2023 to just £2,036 in 2024—an 80% drop in shareholder funds. This represents a severe hemorrhage of value, with retained profits bleeding out by £8,087 over the year.
• Working Capital (Immune System): Net current assets have swung from a positive £10,266 to a negative (£1,034). The current ratio (current assets vs. current liabilities) is 0.98. Anything below 1.0 means the business lacks the short-term immunity to cover its immediate debts without selling off assets or taking on more debt.
• Cash Reserves (Heart Rate): Cash at bank jumped from £39,673 to £71,958. On the surface, this looks like a robust heartbeat, but it is a false positive.
• Creditor Burden (Arterial Plaque): Current liabilities more than doubled from £32,407 to £74,942. The primary blockage is "Other Creditors," which surged from £25,502 to £66,244. This massive buildup restricts financial flow and poses a significant risk to solvency.
• Compliance Health (Vaccination Record): The accounts are marked as overdue. They were approved in June 2025 for a July 2024 year-end, missing the statutory April 2025 deadline. This is a symptom of administrative fatigue or distress.

3. Diagnosis

Acute Equity Depletion with Negative Working Capital Anemia

The patient is suffering from a dangerous imbalance. The financial statements reveal an underlying loss of £8,087 for the year, which has severely weakened the company's equity reserves. While the cash position appears robust, it is suffering from "false positive hypercashemia"—the cash is heavily outweighed by short-term debts.

The massive spike in "Other Creditors" is the critical symptom. In small private companies, this is often money owed to the director (director's loans) or accrued unpaid bills. The business is essentially running on borrowed time, using creditor funding to maintain the appearance of a healthy cash balance while the underlying profitability bleeds out. If these creditors demand repayment, the company would immediately face a liquidity crisis.

4. Recommendations

• Financial Blood Transfusion (Debt Restructuring): If the £66,244 owed to "Other Creditors" includes director loans, consider converting a portion of this debt into equity (share capital). This will reduce the pressure on short-term liabilities, improve the working capital ratio, and transfuse health back into the balance sheet.
• Apply a Tourniquet to Losses: The £8,087 loss must be urgently investigated. For a micro-business, this is a significant hemorrhage. Conduct a thorough review of operating expenses, cost of sales, and margins to stop the equity bleed.
• Treat Cash with Caution: Do not mistake the £71k cash balance for disposable income. It is already spoken for by creditors. Prioritize ensuring that the £7,070 owed in taxation and social security is ring-fenced and paid on time to avoid penalties and enforcement action.
• Administrative Checkup: Ensure all filings with Companies House are made promptly. Late filing incurs automatic financial penalties and can damage the company's credit score, restricting access to future financing.